SCHEMBL13459294

SCHEMBL13459294

CC(C)CNC(=O)c1cc(-c2ccc3nc(-c4ccc(F)cc4)c(C=O)n3c2)ccc1-c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.45
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
HSD17B10 Q99714 1/20 0.41
SLC2A1 P11166 4/20 0.38
F2 P00734 1/20 0.37
F10 P00742 1/20 0.37
F7 P08709 1/20 0.37
F3 P13726 1/20 0.37
CSNK1D P48730 8/20 0.37
CSNK1E P49674 8/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
KDM4E B2RXH2 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2989211 0.87 NPC1 (0.41) ALDH1A1NPC1RAB9AHSD17B10SLC2A1
SCHEMBL2996049 0.79 F2 (0.42) NPC1RAB9AHSD17B10F2F10
SCHEMBL2432043 0.78 EPHB3 (0.39) ALDH1A1NPC1RAB9AHSD17B10SLC2A1
SCHEMBL9911929 0.73 HSD17B10 (0.44) ALDH1A1NPC1RAB9AHSD17B10
SCHEMBL13459295 0.69 F2 (0.39) ALDH1A1NPC1RAB9AHSD17B10F2
SCHEMBL1430562 0.69 ALDH1A1 (0.69) ALDH1A1NPC1RAB9ASLC2A1SMN1; SMN2
SCHEMBL27821938 0.67 NPC1 (0.45) ALDH1A1NPC1RAB9AHSD17B10F2
SCHEMBL16246714 0.66 SLC2A1 (0.57) ALDH1A1NPC1RAB9ASLC2A1
SCHEMBL12164434 0.66 EPHB3 (0.51) ALDH1A1NPC1RAB9ASLC2A1CSNK1D
SCHEMBL15330868 0.65 ALDH1A1 (0.63) ALDH1A1NPC1RAB9ASLC2A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010030538-A2 COMPOUNDS FOR THE TREATMENT OF HEPATITIS C BRISTOL-MYERS SQUIBB COMPANY (US) 2010-03-18 WO disclosed